EQUITY AWARDS (Tables)

3 Months Ended

Mar. 31, 2022

Share-based Payment Arrangement [Abstract]

Schedule of Stock Option Activity

A summary of stock option activity in the Plan during the three months ended March 31, 2022 and 2021 follows:

Three Months Ended March 31, 2022	Number of Shares			Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Life in Years		Aggregate Intrinsic Value
Outstanding at beginning of year		502,780		$	25.77		5.59	$	5,936
Granted		39,000			35.89
Forfeited		(5,060	)		26.92
Balance, March 31, 2022		536,720		$	26.50		5.65	$	4,626
Exercisable at end of period		307,086		$	24.30		4.28	$	3,285

Three Months Ended March 31, 2021	Number of Shares			Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Life in Years		Aggregate Intrinsic Value
Outstanding at beginning of year		506,200		$	26.81		5.82	$	1,805
Effect of 10% stock dividend		50,770
Granted		24,500			33.37
Exercised		(24,250	)		21.74
Forfeited		(10,000	)		28.54
Balance, March 31, 2021		547,220		$	24.81		5.88	$	6,532
Exercisable at end of period		296,922		$	23.49		4.64	$	3,938

Schedule of Nonvested Stock Option Activity

A summary of nonvested stock option activity in the Plan during the three months ended March 31, 2022 and 2021 follows:

Three Months Ended March 31, 2022	Number of Shares			Weighted-Average Grant Date Fair Value
Outstanding at beginning of year		207,084		$	5.23
Granted		39,000			6.03
Vested		(14,030	)		5.21
Forfeited		(2,420	)		9.13
Balance, March 31, 2022		229,634		$	5.38

Three Months Ended March 31, 2021	Number of Shares			Weighted-Average Grant Date Fair Value
Outstanding at beginning of year		214,680		$	4.46
Effect of 10% stock dividend		23,218
Granted		24,500			5.67
Vested		(12,100	)		4.59
Balance, March 31, 2021		250,298		$	5.11

Plan Information

Information related to stock options in the Plan is as follows for the three months ended:

	March 31, 2022		March 31, 2021
Intrinsic value of options exercised	$	—	$	364
Cash received from options exercised		—		527
Weighted average fair value of options granted		6.03		5.67

Summary of Restricted Stock Awards and Units Activity

A summary of restricted stock activity in the Plan during the three months ended March 31, 2022 and 2021 follows:

Three Months Ended March 31, 2022	Number of Shares			Weighted-Average  Grant Date Fair Value
Outstanding at beginning of year		30,190		$	27.52
Vested		(4,070	)		27.50
Balance, March 31, 2022		26,120		$	27.52

Three Months Ended March 31, 2021	Number of Shares			Weighted-Average Grant  Date Fair Value
Outstanding at beginning of year		35,300		$	29.72
Effect of 10% stock dividend		3,530
Vested		(4,840	)		30.25
Balance, March 31, 2021		33,990		$	26.95